SCHEMBL22808277

SCHEMBL22808277

Cc1cccc2c3nccc(I)c3n(C)c12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.51
MEN1 O00255 3/20 0.51
NPC1 O15118 2/20 0.51
HCRTR1 O43613 1/20 0.51
RAB9A P51151 1/20 0.51
ALKBH5 Q6P6C2 1/20 0.44
FTO Q9C0B1 1/20 0.44
HTR1A P08908 1/20 0.40
ADRA1D P25100 1/20 0.40
ADRA1A P35348 1/20 0.40
ADRA1B P35368 1/20 0.40
PSMD14 O00487 2/20 0.39
COPS5 Q92905 2/20 0.39
SLC6A2 P23975 3/20 0.36
HTT P42858 3/20 0.36
ATP4A P20648 2/20 0.35
ATP4B P51164 2/20 0.35
CCR1 P32246 2/20 0.35
CCR8 P51685 2/20 0.35
CCR5 P51681 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22808275 0.88 PSMD14 (0.42) KMT2AMEN1NPC1HCRTR1RAB9A
SCHEMBL21168175 0.87 NPC1 (0.53) KMT2AMEN1NPC1HCRTR1RAB9A
SCHEMBL22808278 0.82 CCR1 (0.41) KMT2AMEN1NPC1HCRTR1RAB9A
SCHEMBL23046421 0.78 ALKBH5 (0.58) KMT2AMEN1NPC1HCRTR1RAB9A
SCHEMBL18848335 0.74 HTR1A (0.56) KMT2AMEN1NPC1RAB9AHTR1A
SCHEMBL18253295 0.74 ALKBH5 (0.59) KMT2AMEN1NPC1HCRTR1RAB9A
SCHEMBL21168176 0.73 ALKBH5 (0.53) KMT2AMEN1NPC1HCRTR1RAB9A
SCHEMBL14931058 0.73 ALKBH5 (0.72) KMT2AMEN1NPC1HCRTR1RAB9A
SCHEMBL22808273 0.71 DYRK1A (0.46) KMT2AMEN1ALKBH5FTOKDM4E
SCHEMBL22808271 0.70 ALKBH5 (0.49) KMT2AMEN1NPC1HCRTR1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10873039-B2 Organometallic compound, organic light-emitting device including the organometallic compound, and diagnostic composition including the organometallic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-12-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10873039-B2 Organometallic compound, organic light-emitting device including the organometallic compound, and diagnostic composition including the organometallic compound ORC3, LEF1, OCIAD1 KMT2A 998/4885MEN1 41/4885NPC1 2591/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.